-
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
Thursday, March 6, 2025 - 3:00am | 583Amgen Inc. (NASDAQ:AMGN) has kicked off two crucial phase three trials for MariTide, its investigational weight loss injection. This move marks a significant step in the company’s pursuit to break into the growing market for obesity drugs. What Happened: The MARITIME program, the drug...
-
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal
Saturday, August 26, 2023 - 12:28pm | 684The Federal Trade Commission (FTC) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc (NASDAQ: AMGN), concerning its proposed acquisition of Horizon Therapeutics PLC (NASDAQ: HZNP) valued at $27.8 billion. The move presents a window of opportunity to contemplate a...
-
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
Sunday, April 4, 2021 - 10:09am | 1149This weekend's Barron's cover story discusses a beleaguered social media giant that is still a buy. Other featured articles share infrastructure picks, capital spending picks and a veteran fund manager's income picks. Also, see the prospects for an up-and-coming biotech, a gold...
-
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
Saturday, March 13, 2021 - 4:43pm | 1201This weekend's Barron's cover story discusses how the U.S. economy could soar as the pandemic fades. Other featured articles discuss why big pharmaceutical stocks are cheap, the outlook for the aerospace industry and what comes next for three meme stocks. Also, the prospects for an...
-
Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More
Sunday, March 25, 2018 - 5:26pm | 773Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included top mining stocks and a Detroit automaker. Bearish calls featured biotech stocks and a key cloud player. Rising concerns about a trade war, another interest rate increase and a social...
-
Benzinga's Weekly Bulls & Bears: Amazon, Apple, GE, Twitter And More
Sunday, January 28, 2018 - 6:31pm | 838Benzinga has featured a look at many investor favorite stocks over the past week. Bullish calls featured the e-commerce leader and a social media giant. Bearish calls included the iPhone maker and a struggling industrial giant. With earnings reporting season in full swing, and as the World...
-
Amgen's Repatha Results Not Good Enough For The Street
Friday, March 17, 2017 - 9:42am | 432Shares of Amgen, Inc. (NASDAQ: AMGN) fell 7 percent after the biotechnology company released data from its therapy called Repatha, which is used to lower the risk of heart attacks, strokes and heart problems. Amgen reported Repatha reduces the risk of heart attacks, stokes and other heart-related...
-
Barron's Picks And Pans: Amgen, Barnes & Noble, Expedia And More
Monday, January 9, 2017 - 7:29am | 585This weekend's Barron's offers the outlook for a private equity giant and a leading online travel booker. The prospects for a biotech giant and a struggling bookseller are also examined. Another featured article offers a look at how Barron's small-cap stock picks for 2016...
-
Barron's Picks And Pans: Best Dividend Stocks, Symantec, GoldCorp And More
Sunday, August 28, 2016 - 11:47am | 713This weekend's Barron's takes a look at 10 dividend stocks with hefty yields and the best prospects for growth. The prospects for a leading fertilizer maker and a software security pioneer are also examined. Other featured articles ponder the prospects for a top gold mining stock and a modular...
-
Barron's: How To Find Safe 5% Yields
Monday, August 8, 2016 - 8:07am | 620The cover story in this weekend's Barron's offers tips and strategies from the panelists at the latest income roundtable. Safe yields of up to 5 percent can be locked in with careful portfolio construction, says veteran fixed-income investors and a dividend stock pro. Another featured article...
-
Barron's Picks And Pans: Monro Muffler Brake, Fidelity National Information Services And More
Sunday, August 7, 2016 - 9:40am | 639This weekend's Barron's ponders the prospects for a leading auto services provider and a financial services technology star. Prospects for two small-cap banks with strong fundamentals are also examined. Other featured articles take a look at what bears such as Bill Gross and...
-
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Sunday, June 12, 2016 - 2:35pm | 588Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...
-
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Friday, May 13, 2016 - 1:26pm | 550Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of one of those two stocks slumped more than 22 percent during the period. Short sellers shied away from many of...
-
Short Sellers Dump Vertex, Load Up On Baxalta
Thursday, April 28, 2016 - 8:34am | 588Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...
-
Big Biotech In The Earnings Spotlight
Tuesday, April 26, 2016 - 8:08am | 735The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...